HUMANIZED ANTI-IL-20 ANTIBODY AND USES THEREOF

Ming-Shi Chang (Inventor)

Research output: Patent

Abstract

The present disclosure provides humanized antibodies specific to human interleukin 20 (IL-20) and uses thereof in treating diseases associated with the IL-20 signaling pathway, e.g., osteoporosis, inflammatory disease (e.g., rheumatoid arthritis), cancer, stroke, and renal failure.
Translated title of the contributionHUMANIZED ANTI-IL-20 ANTIBODY AND USES THEREOF
Original languageEnglish
Patent number9217031
Publication statusPublished - 1800

Fingerprint Dive into the research topics of 'HUMANIZED ANTI-IL-20 ANTIBODY AND USES THEREOF'. Together they form a unique fingerprint.

Cite this